We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Analytical challenges and advances in detecting microplastics in human tissue and organ samples.
AI summary Read the abstract
Scientists have found tiny plastic particles in human blood, lungs, and even placentas, but this review of 218 studies reveals a problem: the tools researchers use to detect microplastics aren't consistently reliable, and many studies skip basic quality checks that would confirm their results are accurate. This matters because until testing methods are standardized, it's hard to know exactly how much plastic is really in our bodies or what health risks it poses, the researchers call for stricter, more consistent lab practices to get trustworthy answers.
Microplastic contamination of biological matrices is a pressing concern in environmental and biomedical research. While their presence has been confirmed in human blood, placentas, lungs, and other tissues, accurate identification remains an analytical challenge. Obstacles include the small size and heterogeneous composition of microplastics, as well as spectral interference from complex organic matter. This review systematically analyzes-following PRISMA 2020 guidelines-the current state of microplastic detection in human tissues, evaluating 218 studies (2000-2024). We focus on the primary techniques: Fourier Transform Infrared (FTIR) and Raman spectroscopy, and Pyrolysis-Gas Chromatography/Mass Spectrometry (Py-GC/MS). Our analysis confirms FTIR as the most widely employed technique, followed by Raman and Py-GC/MS, with each method exhibiting distinct advantages and limitations in sensitivity, specificity, and sample preparation requirements. A critical finding is the widespread lack of robust quality assurance; notably, few studies consistently implemented blank controls and spike-recovery experiments, thereby compromising the reproducibility and reliability of data. In response, we propose a consolidated framework of best practices for sample handling, contamination control, and analytical validation. This review underscores the urgent need for standardized, validated protocols to refine analytical techniques, ensure consistent results, and ultimately support accurate risk assessment of human exposure to microplastics.
More Papers Like This
Micro- and nanoplastics in human biological materials: a systematic review of detection methods and methodological challenges
AI summary Read the abstract
Scientists have found tiny plastic particles in human organs like the placenta, liver, lungs, and kidneys, but this review of existing research reveals a big problem: labs around the world are testing for these particles in wildly inconsistent ways, using different tools, definitions, and measurement units. This makes it hard to know exactly how much plastic is really in our bodies or what health risks it poses—meaning we need more standardized research before drawing firm conclusions about how worried we should be.
Emerging Analytical Methodologies for Micro- and Nano-Plastics Detection in Human Samples: Analytical Challenges and Health Risk Perspectives
AI summary Read the abstract
Scientists have found tiny plastic particles (microplastics and even smaller nanoplastics) throughout human organs and body fluids, but this review of existing research shows we still lack reliable, standardized tools to accurately measure them—different labs get different results depending on how they prepare and test samples. While lab studies suggest very small plastic particles can cause cell stress and inflammation, there isn't yet solid evidence directly linking plastic exposure to specific diseases in people—so the biggest takeaway is that we urgently need better testing methods before we can truly understand the health risks these particles pose.
The analytical challenge of measuring micro- and nanoplastics in human tissues
AI summary Read the abstract
Scientists keep finding tiny plastic particles in human tissue, but measuring them accurately is surprisingly hard, different labs use different methods and get different results. This paper explains why better, more standardized testing tools are urgently needed before we can truly understand how much plastic is in our bodies and what it might be doing to our health.
Analytical Methods for Microplastic Detection in Hepatic and Gastrointestinal Human Tissues: A Review and Methodological Framework
AI summary Read the abstract
Scientists have found tiny plastic particles (microplastics) in human liver and gut tissue, but this review shows that different labs use very different methods to detect them, making it hard to compare results or know how much plastic is really in our bodies. The researchers didn't discover new health risks, instead, they're calling for standardized testing methods so future studies can give us clearer, more reliable answers about how microplastics affect our health.
A QA/QC screening framework to assess studies reporting microplastic presence in human organs, tissues, and bodily fluids
AI summary Read the abstract
Scientists reviewed 101 studies that claimed to find microplastics in human organs, tissues, and body fluids—and found that not a single one used rigorous enough methods to fully trust the results. This doesn't mean microplastics aren't in our bodies, but it does mean we can't yet be confident about how much, where, or what that means for our health, so more careful research is needed before drawing firm conclusions.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.